Insulin-dependent diabetes mellitus

Cell

Volumn 85, Issue 3, 1996, Pages 291-297

  Tisch, Roland ^a   McDevitt, Hugh ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; GLUTAMATE DECARBOXYLASE; HEAT SHOCK PROTEIN; INSULIN; MONOCLONAL ANTIBODY;

AUTOIMMUNITY; CELLULAR IMMUNITY; CLINICAL TRIAL; ETIOLOGY; HUMAN; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE;

EID: 0029954214     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81106-X     Document Type: Review

References (61)

1. Acha-Orbea, H., and McDevitt, H.O. (1987). The first external domain of the non-obese diabetic mouse class II I-Aβ chain is unique. Proc. Natl. Acad. Sci. USA 84, 2435-2439.
2. + β islet cell reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice. J. Exp. Med. 182, 87-97.
3. Atkinson, M.A., and Maclaren, N.K. (1993). Islet cell autoantigens in insulin-dependent diabetes. J. Clin. Invest. 92, 1608-1616.
4. Atkinson, M.A., Bowman, M.A., Campbell, L., Darrow, B.L, Kaufman, D.L., and Maclaren, N.K. (1994). Cellular immunity to a determinant common to glutamic acid decarboxylase and Coxsackie virus in insulin dependent diabetes. J. Clin. Invest. 94, 2125-2129.
5. Baekkeskov, S., Aanstoot, H.J., Christgau, S., Reetz, A., Solimena, M., Cascalho, M., Folli, F., Richter-Olesen, W., and de Camilli, P. (1990). Identification of the 64K autoantigen in insulin dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347, 151-156.
6. Barnett, A.H., Eff, C., Leslie, R.D.G., and Pyke, D.A. (1981). Diabetes in identical twins: a study of 200 pairs. Diabetologia 20, 404-409.
7. Boitard, C., Bendelac, A., Richard, M.F., Carnaud, C., and Bach, J.F. (1988). Prevention of diabetes in nonobese diabetic mice by anti-I-A monoclonal antibodies: transfer of protection by splenic T cells. Proc. Natl. Acad. Sci. USA 85, 9719-9723.
8. Castano, L., and Eisenbarth, G.S. (1990). Type I diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu. Rev. Immunol. 8, 647-680.
9. Chatenoud, L., Thervet, E., Primo, J., and Bach, J.F. (1993). Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc. Natl. Acad. Sci. USA 91, 123-127.
10. Christie, M.R., Genovese, S., Cassidy, D., Bosi, E., Brown, T.J., Lai, M., Bonifacio, E., and Bottazzo, G.F. (1994). Antibodies to islet 37K antigen, but not to glutamic acid decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity. Diabetes 43, 1254-1259.
11. Conrad, B., Weidmann, E., Trucco, G., Rudert, W.A., Behboo, R., Ricordi, C., Rodriguez-Rilo, H., Finegold, D., and Trucco, M. (1994). Evidence for superantigen involvement in insulin dependent diabetes mellitus aetiology. Nature 371, 351-355.
12. Cucca, F., Lampis, R., Frau, F., Macis, D., Angius, E., Masile, P., Chessa, M., Frongia, P., Silvetti, M., Cao, A., DeVirgiliis, S., and Congia, M. (1995). The distribution of DR4 haplotypes in Sardinia suggests a primary association of type I diabetes with DRB1 and DQB1 loci. Human Immunol. 43, 301-308.
13. Daniel, D., Gill, R.G., Schloot, N., and Wegman, D. (1995). Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur. J. Immunol. 25, 1056-1062.
14. Elias, D., and Cohen, I.R. (1994). Peptide therapy for diabetes in NOD mice. Lancet 343, 704-706.
15. Elias, D., Reshef, T., Birk, O.S., van der Zee, R., Walker, M.D., and Cohen, I.R. (1991). Vaccination against autoimmune mouse diabetes with a T cell epitope of the human 65-kDa heat shock protein. Proc. Natl. Acad. Sci. USA 88, 3088-3091.
16. Elliott, J.F., Qin, H.Y., Bhatti, S., Smith, D.K., Singh, R.K., Fraga, E., Dillon, T., Lauzon, J., and Singh, B. (1994). Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice. Diabetes 43, 1494-1499.
17. Erlich, H.A., Zeidler, A., Chang, J., Shaw, S., Raffel, L.J., Klitz, W., Beshkov, Y., Costin, G., Pressman, S., and Bugawan, T. (1993). HLA class II allelesand susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families. Nature Genetics 3, 358-363.
18. + T cell subset that inhibits this autoimmune potential. J. Exp. Med. 177, 627-636.
19. Hagopian, W.A., Karlsen, A.E., Gottsater, A., Landin-Olsson, M., Grubin, C.E., Sundkvist, G., Petersen, J.S., Boel, E., Dyrberg, T., and Lernmark, A. (1993). Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type I. J. Clin. Invest. 91, 368-374.
20. Harrison, L.C., Honeyman, M.C., de Aizpurua, H.J., Schmidli, R.S., Colman, P.G., Tait, B.D., and Cram, D.S. (1993). Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin dependent diabetes. Lancet 341, 1365-1369.
21. + islet-specific T cell clone. Science 249, 1433-1436.
22. Ikegami, H., Kawaguchi, Y., Ueda, H., Fukeda, M., Takakawa, K., Fujioka, Y., Fujisawa, T., Uchida, K., and Ogihara, T. (1993). MHC linked diabetogenic gene of the NOD mouse: molecular mapping of the 3' boundary of the diabetogenic region. Biochem. Biophys. Res. Commun. 192, 677-682.
23. Jarpe, A.J., Hickman, M.R., Anderson, JT., Winter, W.E., and Peck, A.D. (1991). Flow cytometric enumeration of mononuclearcell populations infiltrating the islets of Langerhans in prediabetic NOD mice: development of a model of autoimmune insulitis for type I diabetes. Reg. Immunol. 3, 305-317.
24. Katz, J., Benoist, C., and Mathis, D. (1993a). Major histocompatibility complex class I molecules are required for the development of insulitis in nonobese diabetic mice. Eur. J. Immunol. 23, 3358-3360.
25. Katz, J.D., Wang, B., Haskins, K., Benoist, C., and Mathis, D. (1993b). Following a diabetogenic T cell from genesis through pathogenesis. Cell 74, 1089-1100.
26. Katz, J.D., Benoist, C., and Mathis, D. (1995). T helper cell subsets in insulin dependent diabetes. Science 268, 1185-1188.
27. Kaufman, D.L., Clare-Salzler, M., Tian, J., Forsthuber, T., Ting, G.S., Robinson, P., Atkinson, M.A., Sercarz, E.E., Tobin, A.J., and Lehmann, P.V. (1993). Spontaneous loss of T cell tolerance to glutamic acid decarboxylase in murine insulin dependent diabetes. Nature 366, 69-72.
28. Keller, R.J., Eisenbarth, G.S., and Jackson, R.A. (1993). Insulin prophylaxis in individuals at high risk of type I diabetes. Lancet 341, 927-928.
29. Larger, E., Secourt, C., Bach, J.F., and Boitard, C. (1995). Pancreatic islet β cells drive T cell-immune responses in the nonobese diabetic mouse model. J. Exp. Med. 181, 1635-1642.
30. Lenschow, D.J., Ho, S.C., Sattar, H., Rhee, L., Gray, G., Nabavi, N., Herold, K.C., and Bluestone, J.A. (1995). Differential effects of anti-B7-1 and anti-B7-2 monoclonal treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181, 1145-1155.
31. Muir, A., Peck, A., Clare-Salzler, M., Song, Y.H., Cornelius, J., Luchetta, R., Krischer, J., and Maclaren, N. (1995). Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-γ transcription. J. Clin. Invest. 95, 628-634.
32. Nepom, G.T. (1990). A unified hypothesis for the complex genetics of HLA associations with IDDM. Diabetes 39, 1153-1157.
33. Nepom, G.T., and Erlich, H. (1991). MHC class II molecules and autoimmunity. Annu. Rev. Immunol. 9, 493-525.
34. Passini, N., Larigan, J.D., Genovese, S., Appella, E., Sinigaglia, F., and Rogge, L. (1995). The 37/40 kilodalton autoantigen in insulin dependent diabetes mellitus is the putative tyrosine phosphatase IA-2. Proc. Natl. Acad. Sci. USA 92, 9412-9416.
35. Pennline, K.J., Roque-Gaffney, E., and Monahan, M. (1994). Recombinant human IL-10 (rHUIL-10) prevents the onset of diabetes in the nonobese diabetic (NOD) mouse. Clin. Immunol. Immunopathol. 71, 169-175.
36. Pfeiffer, C., Stein, J., Southwood, S., Ketelaar, H., Sette, A., and Bottomly, K. (1995). Altered peptide ligands can control CD 4 T lymphocyte differentiation in vivo. J. Exp. Med. 181, 1569-1574.
37. Pietropaolo, M., Castano, L., Babu, S., Buelow, R., Kuo, Y.L., Martin, S., Martin, A., Powers, A.C., Prochazka, M., Naggert, J., Leiter, E.H., and Eisenbarth, G.S. (1993). Islet cell autoantigen 69 kD (ICA69). Molecular cloning and characterization of a novel diabetes-associated autoantigen. J. Clin. Invest. 92, 359-371.
38. g7 b-chain diminishes the spontaneous incidence of insulin-dependent diabetes mellitus. J. Immunol. 154, 5567-5575.
39. Rabinovitch, A. (1994). Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation. Diabetes 43, 613-621.
40. Ramensee, H.C., Friede, T., and Stevanovic, S. (1995). MHC ligands and peptide motifs: first listing. Immunogenetics 41, 178-228.
41. Rapoport, M.J., Jaramillo, A., Zipris, D., Lazarus, A.H., Serreze, D.V., Leiter, E.H., Cyopick, P., Danska, J.S., and Delovitch, T.L. (1993). II-4 reverses T cell proliferation unresponsiveness and prevents the onset of diabetes in NOD mice. J. Exp. Med. 178, 87-99.
42. Reich, E.P., von Grafenstein, H., Barlow, A., Swenson, K.E., Williams, K., and Janeway, C.A. (1994). Self peptides isolated from MHC glyco-proteins of non-obese diabetic mice. J. Immunol. 152, 2279-2288.
43. Roep, B.O., Arden, S.D., de Vries, R.R., and Hutton, J.C. (1990). T cell clones from a type I diabetes patient respond to insulin secretory granule proteins. Nature 345, 632-634.
44. Scott, B., Liblau, R., Degermann, S., Marconi, L.A., Ogata, L., Caton, A.J., McDevitt, H.O., and Lo, D. (1994). A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1, 73-82.
45. Sempe, P., Bedossa, P., Richard, M.F., Villa, M.C., Bach, J.F., and Boitard, C. (1991). Anti-α/β T cell receptor monoclonal antibody provides an efficient therapy for autoimmune diabetes in nonobese diabetic (NOD) mice. Eur. J. Immunol. 21, 1163-1169.
46. Serreze, D.V., Leiter, E.H., Christianson, G.J., Greiner, D., and Roopenian, D.C. (1994). Major histocompatibility complex I deficient NOD-B2m null mice are diabetes and insulitis resistant. Diabetes 43, 505-509.
47. Shehadeh, N.N., Larosa, F., and Lafferty, K.J. (1993). Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J. Autoimmun. 6, 291-300.
48. + T cells in nonobese diabetic mice. J. Immunol. 151, 1723-1730.
49. Shizuru, J.A., Taylor-Edwards, C., Banks, B.A., Gregory, A.K., and Fathman, C.G. (1988). Immunotherapy of the nonobese diabetic mouse; treatment with an antibody to T helper lymphocytes. Science 240, 659-662.
50. d transgene prevents diabetes in nonobese diabetic mice by inducing regulatory T cells. Proc. Natl. Acad. Sci. USA 90, 9566-9595.
51. Stern, L.J., Brown, J.H., Jardetzky, T.H., Urban, R., Strominger, J.L., and Wiley, D.C. (1994). Crystal structure of the human class II MHC protein HLA DR1 complexed with an influenza virus peptide. Nature London 368, 215-223.
52. Thai, A.C., and Eisenbarth, G.S. (1993). Natural history of IDDM. Diabetes Rev. 123, 37-64.
53. Tisch, R., Yang, X.D., Singer, S.M., Liblau, R.S., Fugger, L., and McDevitt, H.O. (1993). Immune response to glutamic acid decarboxylase correlates with insulitis in nonobese diabetic mice. Nature 366, 72-75.
54. Todd, J., Bell, J., and McDevitt, H.O. (1987). HLA-DQ B gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329, 599-604.
55. Vyse, T.J., and Todd, J.A. (1996). Genetic analysis of autoimmune disease. Cell, this issue.
56. Wicker, L.S., Appel, M.C., Dotta, F., Pressey, A., Miller, B.J., DeLarato, N.H., Fischer, P.A., Boltz, R.C., and Peterson, L.B. (1992). Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The MHC is dominant for insulitis and cyclophosphamide-induced diabetes. J. Exp. Med. 176, 67-77.
57. Wicker, L.S., Leiter, E.H., Todd, J.A., Renjilian, R.J., Peterson, E., Fischer, P.A., Podolin, P.L., Zijlstra, M., Jaenisch, R., and Peterson, L.B. (1994). b2-microglobulin deficient NOD mice do not develop insulitis or diabetes. Diabetes 43, 500-504.
58. Wicker, L.S., Todd, J.A., and Peterson, L.B. (1995). Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13, 179-200.
59. Wucherpfennig, K.W., and Strominger, J.L. (1995). Selective binding of self peptides to disease-associated MHC molecules: a mechanism for MHC linked susceptibility to human autoimmune disease. J. Exp. Med. 181, 1597-1601.
60. Yang, X.D., Karin, N., Tisch, R., Steinman, L., and McDevitt, H.O. (1993). Inhibition of insulitis and prevention of diabetes in nonobese diabetic mice by blocking L-selectin and very lateantigen 4 adhesion receptors. Proc. Natl. Acad. Sci. USA 90, 10494-10498.
61. Zhang, Z.J., Davidson, L., Eisenbarth, G., and Weiner, H.L. (1991). Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc. Natl. Acad. Sci. USA 88, 10252-10256.